Related Experiment Video
Updated: May 29, 2026

10:10
Robotic Duodenum-preserving Total Pancreatic Head Resection for Intraductal Papillary Mucinous Neoplasms
Published on: April 17, 2026
Growth pattern of serous cystic neoplasms of the pancreas: observational study with long-term magnetic resonance
Giuseppe Malleo1, Claudio Bassi, Roberto Rossini
1Department of Surgery, General Surgery B, GB Rossi Hospital, Ple LA Scuro 10, 37134 Verona, Italy.
Gut
|September 24, 2011
Summary
Pancreatic serous cystic neoplasms (SCNs) generally grow slowly, with accelerated growth observed after seven years. Factors like tumor pattern, patient history, and age influence SCN growth, guiding management strategies.
Area of Science:
- Gastroenterology
- Oncology
- Radiology
Background:
- Pancreatic serous cystic neoplasms (SCNs) are tumors with poorly understood natural history and growth patterns.
- Accurate assessment of SCN growth is crucial for effective patient management and treatment decisions.
Purpose of the Study:
- To investigate the growth rate of SCNs using longitudinal data.
- To identify factors influencing SCN growth and inform clinical management recommendations.
Main Methods:
- Analysis of 145 patients with SCNs undergoing yearly surveillance MRI.
- Application of a linear mixed model to assess tumor growth rate and influencing factors (sex, malignancy history, radiological pattern, clinical presentation, tumor site, age, initial tumor diameter).
Main Results:
- Overall mean SCN growth rate was 0.28 cm/year, with a slower rate (0.1 cm/year) in the first 7 years and accelerated growth (0.6 cm/year) thereafter (p<0.0001).
- Oligocystic/macrocystic pattern (0.34 cm/year), history of other malignancies (0.34 cm/year), and increasing age were significant predictors of faster growth (p<0.0001, p=0.022, p=0.0001, respectively).
Conclusions:
- SCNs exhibit slow growth, supporting a conservative, non-operative approach for asymptomatic or minimally symptomatic patients.
- Tumor characteristics (oligocystic/macrocystic variant), patient history (other malignancies), and age are key determinants of SCN growth.
- Significant growth is unlikely within the first 7 years; tumor size at diagnosis is not a reliable factor for management decisions.
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
Chronic Pancreatitis I: Introduction
Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
